Risk assessment and associated preventative care strategies are now at the forefront of government and private health plan thoughts on controlling the unnecessary costs associated with diabetic foot complications.

The evidence to justify the need for risk stratification is supported by a number of cross-sectional and prospective studies. These studies state that it is possible to identify individual patients with clinical features linked to the risk of future foot ulceration.

When individualized foot risk stratification is followed by adoption of effective and proven Population Health Management (PHM) strategies the incidences of foot complications and their associated costs will fall.1


Arche’s CLUE® and HealthStep® PHM tools are uniquely architected around our proprietary diagnostic device portfolio and insightful analytic data.

An individualized program of risk stratification and proactive prevention for people with diabetes can reduce amputations by 50%.2

1The system of care for the diabetic foot: objectives, outcomes, and opportunities NR. Barshes, MD, MPH1*, MSigireddi, MPH2, JS. Wrobel, DPM, MS3, Archana Mahankali, MD4, JM. Robbins, DPM5, Panos Kougias, MD6 and DG. Armstrong, DPM, MD, PhD7

2LA. Lavery, RP. Wunderlich, JL. Tredwell (2005) 70 31–37 Disease management for the diabetic foot: Effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations; Diabetes Research and Clinical Practice